論文

査読有り 筆頭著者 国際誌
2020年12月22日

Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone.

Nature communications
  • Dohyun Im
  • Asuka Inoue
  • Takaaki Fujiwara
  • Takanori Nakane
  • Yasuaki Yamanaka
  • Tomoko Uemura
  • Chihiro Mori
  • Yuki Shiimura
  • Kanako Terakado Kimura
  • Hidetsugu Asada
  • Norimichi Nomura
  • Tomoyuki Tanaka
  • Ayumi Yamashita
  • Eriko Nango
  • Kensuke Tono
  • Francois Marie Ngako Kadji
  • Junken Aoki
  • So Iwata
  • Tatsuro Shimamura
  • 全て表示

11
1
開始ページ
6442
終了ページ
6442
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1038/s41467-020-20221-0

In addition to the serotonin 5-HT2A receptor (5-HT2AR), the dopamine D2 receptor (D2R) is a key therapeutic target of antipsychotics for the treatment of schizophrenia. The inactive state structures of D2R have been described in complex with the inverse agonists risperidone (D2Rris) and haloperidol (D2Rhal). Here we describe the structure of human D2R in complex with spiperone (D2Rspi). In D2Rspi, the conformation of the extracellular loop (ECL) 2, which composes the ligand-binding pocket, was substantially different from those in D2Rris and D2Rhal, demonstrating that ECL2 in D2R is highly dynamic. Moreover, D2Rspi exhibited an extended binding pocket to accommodate spiperone's phenyl ring, which probably contributes to the selectivity of spiperone to D2R and 5-HT2AR. Together with D2Rris and D2Rhal, the structural information of D2Rspi should be of value for designing novel antipsychotics with improved safety and efficacy.

リンク情報
DOI
https://doi.org/10.1038/s41467-020-20221-0
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33353947
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755896
ID情報
  • DOI : 10.1038/s41467-020-20221-0
  • PubMed ID : 33353947
  • PubMed Central 記事ID : PMC7755896

エクスポート
BibTeX RIS